MARKET

LVCLF

LVCLF

Algorae Pharmaceuticals
OTCPK
0.0064
NaN%
Opening 09:30 02/13 EST
OPEN
--
PREV CLOSE
0.0064
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0070
52 WEEK LOW
0.0015
MARKET CAP
10.81M
P/E (TTM)
-21.3333
1D
5D
1M
3M
1Y
5Y
1D
Algorae expands ANZ generics portfolio with Cadila cardiovascular and metabolic deal
TipRanks · 4d ago
Algorae Issues Confidential Non-Deal Investor Presentation with Strong Risk Disclaimers
TipRanks · 02/02 22:34
Algorae Pharmaceuticals Seeks ASX Quotation for 47,745 New Shares
TipRanks · 02/02 09:44
Algorae Pharmaceuticals Advances AI Drug Platform and Oncology Commercial Push
TipRanks · 01/27 23:07
Algorae Secures A$3m ScotPac Facility to Scale ANZ Commercial Operations
TipRanks · 01/20 22:38
Algorae Director Increases Equity Exposure Through Loyalty Option Offer
TipRanks · 12/22/2025 01:18
Algorae Pharmaceuticals Issues 199 Million Unquoted Options Expiring in 2029
TipRanks · 12/22/2025 00:37
Algorae Pharmaceuticals Seeks ASX Quotation for Additional Ordinary Shares
TipRanks · 12/19/2025 07:34
More
About LVCLF
Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI) enabled pharmaceutical development company. The Company’s proprietary AI platform, Algorae Operating System (AlgoraeOS), is an AI platform that leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. Its other drug candidates include AI-116, AI-168, NTCELL. AI-116 is a combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualized to be a potential treatment for dementia, including Alzheimer’s disease. AI-168 is a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient, which is conceptualized to be a potential treatment for cardiovascular disease, including hypertension. NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells.

Webull offers Algorae Pharmaceuticals Ltd stock information, including OTCPK: LVCLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LVCLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LVCLF stock methods without spending real money on the virtual paper trading platform.